Recent technological advances indicate that NfL levels measured in the blood, i.e., plasma NfL, are associated with AD diagnosis and with various cognitive, imaging, and biochemical disease measures [1, 15, 35]. This evidence concerns the gene NEFL and Alzheimer disease.